Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.

Identifieur interne : 000179 ( Main/Exploration ); précédent : 000178; suivant : 000180

Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.

Auteurs : Iván Martínez-Baz [Espagne] ; Ana Navascués ; Francisco Pozo ; Judith Chamorro ; Esther Albeniz ; Itziar Casado ; Gabriel Reina ; Manuel García Cenoz ; Carmen Ezpeleta ; Jesús Castilla

Source :

RBID : pubmed:25996366

Descripteurs français

English descriptors

Abstract

Studies that have evaluated the influenza vaccine effectiveness (VE) to prevent laboratory-confirmed influenza B cases are uncommon, and few have analyzed the effect in preventing hospitalized cases. We have evaluated the influenza VE in preventing outpatient and hospitalized cases with laboratory-confirmed influenza in the 2012-2013 season, which was dominated by a vaccine-matched influenza B virus. In the population covered by the Navarra Health Service, all hospitalized patients with influenza-like illness (ILI) and all ILI patients attended by a sentinel network of general practitioners were swabbed for influenza testing, and all were included in a test-negative case-control analysis. VE was calculated as (1-odds ratio) × 100. Among 744 patients tested, 382 (51%) were positive for influenza virus: 70% for influenza B, 24% for A(H1N1)pdm09, and 5% for A(H3N2). The overall estimate of VE in preventing laboratory-confirmed influenza was 63% (95% confidence interval (CI): 34 to 79), 55% (1 to 80) in outpatients and 74% (33 to 90) in hospitalized patients. The VE was 70% (41 to 85) against influenza B and 43% (-45 to 78) against influenza A. The VE against virus B was 87% (52 to 96) in hospitalized patients and 56% in outpatients (-5 to 81). Adjusted comparison of vaccination status between inpatient and outpatient cases with influenza B did not show statistically significant differences (odds ratio: 1.13; p = 0.878). These results suggest a high protective effect of the vaccine in the 2012-2013 season, with no differences found for the effect between outpatient and hospitalized cases.

DOI: 10.1080/21645515.2015.1038002
PubMed: 25996366
PubMed Central: PMC4514388


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.</title>
<author>
<name sortKey="Martinez Baz, Ivan" sort="Martinez Baz, Ivan" uniqKey="Martinez Baz I" first="Iván" last="Martínez-Baz">Iván Martínez-Baz</name>
<affiliation wicri:level="1">
<nlm:affiliation>a Instituto de Salud Pública de Navarra ; Pamplona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>a Instituto de Salud Pública de Navarra ; Pamplona </wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Navascues, Ana" sort="Navascues, Ana" uniqKey="Navascues A" first="Ana" last="Navascués">Ana Navascués</name>
</author>
<author>
<name sortKey="Pozo, Francisco" sort="Pozo, Francisco" uniqKey="Pozo F" first="Francisco" last="Pozo">Francisco Pozo</name>
</author>
<author>
<name sortKey="Chamorro, Judith" sort="Chamorro, Judith" uniqKey="Chamorro J" first="Judith" last="Chamorro">Judith Chamorro</name>
</author>
<author>
<name sortKey="Albeniz, Esther" sort="Albeniz, Esther" uniqKey="Albeniz E" first="Esther" last="Albeniz">Esther Albeniz</name>
</author>
<author>
<name sortKey="Casado, Itziar" sort="Casado, Itziar" uniqKey="Casado I" first="Itziar" last="Casado">Itziar Casado</name>
</author>
<author>
<name sortKey="Reina, Gabriel" sort="Reina, Gabriel" uniqKey="Reina G" first="Gabriel" last="Reina">Gabriel Reina</name>
</author>
<author>
<name sortKey="Cenoz, Manuel Garcia" sort="Cenoz, Manuel Garcia" uniqKey="Cenoz M" first="Manuel García" last="Cenoz">Manuel García Cenoz</name>
</author>
<author>
<name sortKey="Ezpeleta, Carmen" sort="Ezpeleta, Carmen" uniqKey="Ezpeleta C" first="Carmen" last="Ezpeleta">Carmen Ezpeleta</name>
</author>
<author>
<name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25996366</idno>
<idno type="pmid">25996366</idno>
<idno type="doi">10.1080/21645515.2015.1038002</idno>
<idno type="pmc">PMC4514388</idno>
<idno type="wicri:Area/Main/Corpus">00171</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00171</idno>
<idno type="wicri:Area/Main/Curation">000171</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000171</idno>
<idno type="wicri:Area/Main/Exploration">000171</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.</title>
<author>
<name sortKey="Martinez Baz, Ivan" sort="Martinez Baz, Ivan" uniqKey="Martinez Baz I" first="Iván" last="Martínez-Baz">Iván Martínez-Baz</name>
<affiliation wicri:level="1">
<nlm:affiliation>a Instituto de Salud Pública de Navarra ; Pamplona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>a Instituto de Salud Pública de Navarra ; Pamplona </wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Navascues, Ana" sort="Navascues, Ana" uniqKey="Navascues A" first="Ana" last="Navascués">Ana Navascués</name>
</author>
<author>
<name sortKey="Pozo, Francisco" sort="Pozo, Francisco" uniqKey="Pozo F" first="Francisco" last="Pozo">Francisco Pozo</name>
</author>
<author>
<name sortKey="Chamorro, Judith" sort="Chamorro, Judith" uniqKey="Chamorro J" first="Judith" last="Chamorro">Judith Chamorro</name>
</author>
<author>
<name sortKey="Albeniz, Esther" sort="Albeniz, Esther" uniqKey="Albeniz E" first="Esther" last="Albeniz">Esther Albeniz</name>
</author>
<author>
<name sortKey="Casado, Itziar" sort="Casado, Itziar" uniqKey="Casado I" first="Itziar" last="Casado">Itziar Casado</name>
</author>
<author>
<name sortKey="Reina, Gabriel" sort="Reina, Gabriel" uniqKey="Reina G" first="Gabriel" last="Reina">Gabriel Reina</name>
</author>
<author>
<name sortKey="Cenoz, Manuel Garcia" sort="Cenoz, Manuel Garcia" uniqKey="Cenoz M" first="Manuel García" last="Cenoz">Manuel García Cenoz</name>
</author>
<author>
<name sortKey="Ezpeleta, Carmen" sort="Ezpeleta, Carmen" uniqKey="Ezpeleta C" first="Carmen" last="Ezpeleta">Carmen Ezpeleta</name>
</author>
<author>
<name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name>
</author>
</analytic>
<series>
<title level="j">Human vaccines & immunotherapeutics</title>
<idno type="eISSN">2164-554X</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Case-Control Studies (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Electronic Health Records (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H3N2 Subtype (immunology)</term>
<term>Influenza B virus (immunology)</term>
<term>Influenza B virus (pathogenicity)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Inpatients (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Odds Ratio (MeSH)</term>
<term>Outpatients (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Sentinel Surveillance (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Time Factors (MeSH)</term>
<term>Vaccine Potency (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Dossiers médicaux électroniques (MeSH)</term>
<term>Efficacité du vaccin (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Facteurs temps (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Odds ratio (MeSH)</term>
<term>Patients en consultation externe (MeSH)</term>
<term>Patients hospitalisés (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H3N2 du virus de la grippe A (immunologie)</term>
<term>Sujet âgé (MeSH)</term>
<term>Surveillance sentinelle (MeSH)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Virus influenza B (immunologie)</term>
<term>Virus influenza B (pathogénicité)</term>
<term>Études cas-témoins (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Electronic Health Records</term>
<term>Female</term>
<term>Humans</term>
<term>Inpatients</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Outpatients</term>
<term>Seasons</term>
<term>Sentinel Surveillance</term>
<term>Time Factors</term>
<term>Vaccine Potency</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Dossiers médicaux électroniques</term>
<term>Efficacité du vaccin</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Odds ratio</term>
<term>Patients en consultation externe</term>
<term>Patients hospitalisés</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Surveillance sentinelle</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Studies that have evaluated the influenza vaccine effectiveness (VE) to prevent laboratory-confirmed influenza B cases are uncommon, and few have analyzed the effect in preventing hospitalized cases. We have evaluated the influenza VE in preventing outpatient and hospitalized cases with laboratory-confirmed influenza in the 2012-2013 season, which was dominated by a vaccine-matched influenza B virus. In the population covered by the Navarra Health Service, all hospitalized patients with influenza-like illness (ILI) and all ILI patients attended by a sentinel network of general practitioners were swabbed for influenza testing, and all were included in a test-negative case-control analysis. VE was calculated as (1-odds ratio) × 100. Among 744 patients tested, 382 (51%) were positive for influenza virus: 70% for influenza B, 24% for A(H1N1)pdm09, and 5% for A(H3N2). The overall estimate of VE in preventing laboratory-confirmed influenza was 63% (95% confidence interval (CI): 34 to 79), 55% (1 to 80) in outpatients and 74% (33 to 90) in hospitalized patients. The VE was 70% (41 to 85) against influenza B and 43% (-45 to 78) against influenza A. The VE against virus B was 87% (52 to 96) in hospitalized patients and 56% in outpatients (-5 to 81). Adjusted comparison of vaccination status between inpatient and outpatient cases with influenza B did not show statistically significant differences (odds ratio: 1.13; p = 0.878). These results suggest a high protective effect of the vaccine in the 2012-2013 season, with no differences found for the effect between outpatient and hospitalized cases.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25996366</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>05</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2164-554X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Human vaccines & immunotherapeutics</Title>
<ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.</ArticleTitle>
<Pagination>
<MedlinePgn>1626-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2015.1038002</ELocationID>
<Abstract>
<AbstractText>Studies that have evaluated the influenza vaccine effectiveness (VE) to prevent laboratory-confirmed influenza B cases are uncommon, and few have analyzed the effect in preventing hospitalized cases. We have evaluated the influenza VE in preventing outpatient and hospitalized cases with laboratory-confirmed influenza in the 2012-2013 season, which was dominated by a vaccine-matched influenza B virus. In the population covered by the Navarra Health Service, all hospitalized patients with influenza-like illness (ILI) and all ILI patients attended by a sentinel network of general practitioners were swabbed for influenza testing, and all were included in a test-negative case-control analysis. VE was calculated as (1-odds ratio) × 100. Among 744 patients tested, 382 (51%) were positive for influenza virus: 70% for influenza B, 24% for A(H1N1)pdm09, and 5% for A(H3N2). The overall estimate of VE in preventing laboratory-confirmed influenza was 63% (95% confidence interval (CI): 34 to 79), 55% (1 to 80) in outpatients and 74% (33 to 90) in hospitalized patients. The VE was 70% (41 to 85) against influenza B and 43% (-45 to 78) against influenza A. The VE against virus B was 87% (52 to 96) in hospitalized patients and 56% in outpatients (-5 to 81). Adjusted comparison of vaccination status between inpatient and outpatient cases with influenza B did not show statistically significant differences (odds ratio: 1.13; p = 0.878). These results suggest a high protective effect of the vaccine in the 2012-2013 season, with no differences found for the effect between outpatient and hospitalized cases.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Martínez-Baz</LastName>
<ForeName>Iván</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>a Instituto de Salud Pública de Navarra ; Pamplona , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Navascués</LastName>
<ForeName>Ana</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pozo</LastName>
<ForeName>Francisco</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chamorro</LastName>
<ForeName>Judith</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Albeniz</LastName>
<ForeName>Esther</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Casado</LastName>
<ForeName>Itziar</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reina</LastName>
<ForeName>Gabriel</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cenoz</LastName>
<ForeName>Manuel García</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ezpeleta</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Castilla</LastName>
<ForeName>Jesús</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hum Vaccin Immunother</MedlineTA>
<NlmUniqueID>101572652</NlmUniqueID>
<ISSNLinking>2164-5515</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009981" MajorTopicYN="Y">Influenza B virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018571" MajorTopicYN="N">Sentinel Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064166" MajorTopicYN="N">Vaccine Potency</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CI, confidence interval</Keyword>
<Keyword MajorTopicYN="N">ILI, influenza-like illness</Keyword>
<Keyword MajorTopicYN="N">OR, odds ratio</Keyword>
<Keyword MajorTopicYN="N">RT-PCR, reverse transcription polymerase chain reaction</Keyword>
<Keyword MajorTopicYN="N">VE, vaccine effectiveness</Keyword>
<Keyword MajorTopicYN="N">case-control study</Keyword>
<Keyword MajorTopicYN="N">effectiveness</Keyword>
<Keyword MajorTopicYN="N">influenza</Keyword>
<Keyword MajorTopicYN="N">influenza B virus</Keyword>
<Keyword MajorTopicYN="N">influenza vaccine</Keyword>
<Keyword MajorTopicYN="N">sentinel surveillance</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Abad</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aldaz</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Álvarez</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arana</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arceiz</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arina</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arribas</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Artajo</LastName>
<ForeName>M D</ForeName>
<Initials>MD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arza</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Azagra</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bartolome</LastName>
<ForeName>F C</ForeName>
<Initials>FC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bernués</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bolea</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brugos</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cano</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Castresana</LastName>
<ForeName>M V</ForeName>
<Initials>MV</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cenoz</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cia</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Compains</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Corpas</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cortés</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Churío</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cuevas</LastName>
<ForeName>P C</ForeName>
<Initials>PC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Da Costa</LastName>
<ForeName>E M</ForeName>
<Initials>EM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Díez Espino</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Doiz</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Escribano</LastName>
<ForeName>F J</ForeName>
<Initials>FJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Esparza</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Etayo</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fernández Alfaro</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Flamarique</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gamboa</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Garcés</LastName>
<ForeName>M L</ForeName>
<Initials>ML</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>García Blanco</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>German</LastName>
<ForeName>A B</ForeName>
<Initials>AB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giner</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gómara</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Goñi</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guillorme</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guiu</LastName>
<ForeName>J O</ForeName>
<Initials>JO</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gurbindo</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guruchaga</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Heras</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hijos</LastName>
<ForeName>M C</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Indurain</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Iñigo</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Juan Belloc</LastName>
<ForeName>S E</ForeName>
<Initials>SE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jurio</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>León</LastName>
<ForeName>M P</ForeName>
<Initials>MP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Longás</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Miner</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moreno</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moros</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Navarro</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Orozco</LastName>
<ForeName>F J</ForeName>
<Initials>FJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Orte</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Palacio</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Palau</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pérez Lecumberri</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pérez Pascual</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pérez Sanz</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prado Virto</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prado Santamaria</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Puig Arrastia</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ridruejo</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ramos</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rípodas</LastName>
<ForeName>B E</ForeName>
<Initials>BE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rodríguez</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Roncal</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruiz Puertas</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sánchez Vázquez</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sarrasqueta</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Senosiain</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sola</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sota</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ursua</LastName>
<ForeName>M E</ForeName>
<Initials>ME</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Urtasun</LastName>
<ForeName>I A</ForeName>
<Initials>IA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vigata</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Virto</LastName>
<ForeName>M T</ForeName>
<Initials>MT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vizcay</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Artajo</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beristain</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bernaola</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chamorro</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Esquiroz</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fanlo</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gil</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gabari</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hueto</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Martín</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peña</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pérez</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruiz</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fernández-Alonso</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Núñez</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>García Irure</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Torres</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ortega</LastName>
<ForeName>M T</ForeName>
<Initials>MT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lameiro</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barrado</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alvarez</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guevara</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Irisarri</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arriazu</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zabala</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barricarte</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Castilla</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>5</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25996366</ArticleId>
<ArticleId IdType="doi">10.1080/21645515.2015.1038002</ArticleId>
<ArticleId IdType="pmc">PMC4514388</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2012;17(17). pii: 20154</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22551499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wkly Epidemiol Rec. 2012 Mar 9;87(10):83-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22462202</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2013;18(5). pii: 20388</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23399423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2013 Feb 14;368(7):589-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23343038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2013;18(7):2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23449182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013;8(3):e58222</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23472161</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2013;13:191</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23496887</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2013 Jun 26;31(30):3104-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23624093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014;9(3):e92153</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24667168</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2014;19(6). pii: 20701</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24556348</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2013;18(37). pii: 20585</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24079398</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014;9(6):e100497</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24945510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2014 Sep;142(9):1809-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24814635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2014 Nov 15;59(10):1375-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25270645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2014 Dec 1;59(11):1519-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25139969</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2015;20(2). pii: 21011</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25613779</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Vaccin Immunother. 2015;11(1):225-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25483540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2015 May 15;211(10):1529-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25406334</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2006 Apr;35(2):337-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16368725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 Oct 4;357(14):1373-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17914038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2009 Jan 15;199(2):168-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19086914</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Feb 25;28(9):2149-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20003926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Sep 7;28 Suppl 4:D45-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20713260</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Oct 28;28(46):7381-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20851086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22032844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2012 Jan 5;30(2):195-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22100636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2012 Mar 2;30(11):1993-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22226861</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Public Health. 2013 Mar;103(3):e43-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23327249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Espagne</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Albeniz, Esther" sort="Albeniz, Esther" uniqKey="Albeniz E" first="Esther" last="Albeniz">Esther Albeniz</name>
<name sortKey="Casado, Itziar" sort="Casado, Itziar" uniqKey="Casado I" first="Itziar" last="Casado">Itziar Casado</name>
<name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name>
<name sortKey="Cenoz, Manuel Garcia" sort="Cenoz, Manuel Garcia" uniqKey="Cenoz M" first="Manuel García" last="Cenoz">Manuel García Cenoz</name>
<name sortKey="Chamorro, Judith" sort="Chamorro, Judith" uniqKey="Chamorro J" first="Judith" last="Chamorro">Judith Chamorro</name>
<name sortKey="Ezpeleta, Carmen" sort="Ezpeleta, Carmen" uniqKey="Ezpeleta C" first="Carmen" last="Ezpeleta">Carmen Ezpeleta</name>
<name sortKey="Navascues, Ana" sort="Navascues, Ana" uniqKey="Navascues A" first="Ana" last="Navascués">Ana Navascués</name>
<name sortKey="Pozo, Francisco" sort="Pozo, Francisco" uniqKey="Pozo F" first="Francisco" last="Pozo">Francisco Pozo</name>
<name sortKey="Reina, Gabriel" sort="Reina, Gabriel" uniqKey="Reina G" first="Gabriel" last="Reina">Gabriel Reina</name>
</noCountry>
<country name="Espagne">
<noRegion>
<name sortKey="Martinez Baz, Ivan" sort="Martinez Baz, Ivan" uniqKey="Martinez Baz I" first="Iván" last="Martínez-Baz">Iván Martínez-Baz</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000179 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000179 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25996366
   |texte=   Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25996366" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021